{"hands_on_practices": [{"introduction": "Effective control of giardiasis relies heavily on ensuring the safety of public water supplies. This practice moves from theory to application by tackling a core challenge in environmental engineering: calculating the necessary disinfection parameters to inactivate the environmentally-resistant *Giardia* cysts. By applying fundamental principles of chemical kinetics, you will determine the 'Ct' value, a critical public health metric that ensures drinking water is safe from this resilient protozoan. [@problem_id:4633472]", "problem": "A municipal drinking water utility is designing a primary disinfection step aimed at inactivating cysts of the flagellated protozoan Giardia lamblia in cold-source water at $5^{\\circ}\\mathrm{C}$. Inactivation by free chlorine is assumed to follow first-order kinetics in both viable cyst concentration and disinfectant concentration under constant residual conditions, so that the viable count $N(t)$ obeys the differential equation $dN/dt=-k(T)\\,C\\,N$, where $k(T)$ is the temperature-dependent specific inactivation coefficient, $C$ is the maintained free chlorine residual, and $t$ is the contact time. The concentration-time (Ct) product is defined as $Ct=C\\,t$, with $C$ in $\\mathrm{mg}\\,\\mathrm{L}^{-1}$ and $t$ in $\\mathrm{min}$, so its unit is $\\mathrm{mg}\\cdot\\mathrm{min}\\,\\mathrm{L}^{-1}$.\n\nAssume the temperature dependence of the specific inactivation coefficient $k(T)$ is governed by an Arrhenius relationship,\n$$\nk(T)=k_{\\mathrm{ref}}\\exp\\!\\left[-\\frac{E_{a}}{R}\\left(\\frac{1}{T}-\\frac{1}{T_{\\mathrm{ref}}}\\right)\\right],\n$$\nwhere $E_{a}$ is the activation energy, $R$ is the universal gas constant, and $k_{\\mathrm{ref}}$ is the inactivation coefficient measured at reference temperature $T_{\\mathrm{ref}}$. Take $k_{\\mathrm{ref}}=1.7\\times 10^{-4}\\ \\mathrm{L}\\,\\mathrm{mg}^{-1}\\,\\mathrm{min}^{-1}$ at $T_{\\mathrm{ref}}=293.15\\ \\mathrm{K}$, $E_{a}=4.0\\times 10^{4}\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}$, $R=8.314\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}$, and $T=278.15\\ \\mathrm{K}$ for $5^{\\circ}\\mathrm{C}$.\n\nUsing the definition of an $L$ $\\log_{10}$ reduction, namely $N(t)/N(0)=10^{-L}$, derive from first principles the expression for the Ct requirement to achieve $L=3$ $\\log_{10}$ reduction of Giardia cysts at $5^{\\circ}\\mathrm{C}$ and evaluate it numerically with the given parameters. Express your final Ct in $\\mathrm{mg}\\cdot\\mathrm{min}\\,\\mathrm{L}^{-1}$ and round your answer to three significant figures.", "solution": "## PROBLEM VALIDATION\n\n### Step 1: Extract Givens\nThe problem provides the following information:\n- **Governing Differential Equation**: The viable cyst concentration $N(t)$ follows $dN/dt=-k(T)\\,C\\,N$.\n- **Variables and Constants**:\n    - $N(t)$: Viable cyst concentration at time $t$.\n    - $k(T)$: Temperature-dependent specific inactivation coefficient.\n    - $C$: Maintained free chlorine residual, constant.\n    - $t$: Contact time.\n- **Concentration-Time (Ct) Product**: Defined as $Ct=C\\,t$, with units of $\\mathrm{mg}\\cdot\\mathrm{min}\\,\\mathrm{L}^{-1}$.\n- **Arrhenius Relationship**: The temperature dependence of $k(T)$ is given by\n$$k(T)=k_{\\mathrm{ref}}\\exp\\!\\left[-\\frac{E_{a}}{R}\\left(\\frac{1}{T}-\\frac{1}{T_{\\mathrm{ref}}}\\right)\\right]$$\n- **Parameter Values**:\n    - Reference inactivation coefficient, $k_{\\mathrm{ref}}=1.7\\times 10^{-4}\\ \\mathrm{L}\\,\\mathrm{mg}^{-1}\\,\\mathrm{min}^{-1}$.\n    - Reference temperature, $T_{\\mathrm{ref}}=293.15\\ \\mathrm{K}$.\n    - Activation energy, $E_{a}=4.0\\times 10^{4}\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}$.\n    - Universal gas constant, $R=8.314\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}$.\n    - Target water temperature, $T=5^{\\circ}\\mathrm{C}$, which corresponds to $T=278.15\\ \\mathrm{K}$.\n- **Log Reduction Requirement**: A reduction of $L=3$ $\\log_{10}$ is required.\n- **Definition of Log Reduction**: $N(t)/N(0)=10^{-L}$.\n- **Task**: Derive the expression for the required Ct and evaluate it numerically, rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientifically Grounded**: The problem is grounded in established principles of chemical kinetics and environmental engineering. The inactivation model, $dN/dt=-kCN$, is a form of the Chick-Watson law, a standard model for chemical disinfection. The use of the Arrhenius equation to model the temperature dependence of a rate constant is a fundamental concept in physical chemistry.\n- **Well-Posed**: The problem is well-posed. It provides a differential equation, all necessary parameters and constants, and a clearly defined target condition ($3$-log inactivation). This setup allows for the derivation of a unique and meaningful solution for the Ct product.\n- **Objective**: The problem is stated in precise, objective, and quantitative terms. All variables are clearly defined, and the parameters have specified values and units.\n\n### Step 3: Verdict and Action\nThe problem is valid. It is scientifically sound, self-contained, well-posed, and objective. I will proceed with the solution.\n\n## SOLUTION\n\nThe inactivation of *Giardia lamblia* cysts is described by the first-order differential equation:\n$$\n\\frac{dN}{dt} = -k(T) C N\n$$\nwhere $N$ is the concentration of viable cysts, $t$ is time, $C$ is the constant chlorine concentration, and $k(T)$ is the temperature-dependent rate constant. To find the relationship between the initial cyst concentration, $N(0)$, and the concentration at a later time, $N(t)$, we must solve this differential equation. We can separate the variables:\n$$\n\\frac{dN}{N} = -k(T) C \\, dt\n$$\nNext, we integrate both sides. The concentration of cysts changes from $N(0)$ at $t=0$ to $N(t)$ at time $t$. Since $k(T)$ and $C$ are constant with respect to time, the integration is as follows:\n$$\n\\int_{N(0)}^{N(t)} \\frac{1}{N} dN = \\int_{0}^{t} -k(T) C \\, dt\n$$\n$$\n[\\ln(N)]_{N(0)}^{N(t)} = -k(T) C [t]_{0}^{t}\n$$\n$$\n\\ln(N(t)) - \\ln(N(0)) = -k(T) C t\n$$\nUsing the property of logarithms, $\\ln(a) - \\ln(b) = \\ln(a/b)$, we get:\n$$\n\\ln\\left(\\frac{N(t)}{N(0)}\\right) = -k(T) C t\n$$\nThe problem defines the concentration-time product as $Ct = C \\cdot t$. Substituting this into the equation gives:\n$$\n\\ln\\left(\\frac{N(t)}{N(0)}\\right) = -k(T) (Ct)\n$$\nThe problem also specifies an $L$ $\\log_{10}$ reduction, defined by the relation $N(t)/N(0) = 10^{-L}$. We can substitute this into our integrated rate law:\n$$\n\\ln(10^{-L}) = -k(T) (Ct)\n$$\nUsing the logarithm property $\\ln(a^b) = b \\ln(a)$, we have:\n$$\n-L \\ln(10) = -k(T) (Ct)\n$$\nThe negative signs on both sides cancel, yielding:\n$$\nL \\ln(10) = k(T) (Ct)\n$$\nSolving for the required Ct product gives the general expression:\n$$\nCt = \\frac{L \\ln(10)}{k(T)}\n$$\nThis is the derived expression for the Ct requirement. Now, we must evaluate this expression for the given conditions. First, we calculate the specific inactivation coefficient, $k(T)$, at the target temperature of $T=278.15\\ \\mathrm{K}$ using the provided Arrhenius equation and parameters:\n$$\nk(T) = k_{\\mathrm{ref}}\\exp\\!\\left[-\\frac{E_{a}}{R}\\left(\\frac{1}{T}-\\frac{1}{T_{\\mathrm{ref}}}\\right)\\right]\n$$\nSubstituting the given values:\n$k_{\\mathrm{ref}}=1.7\\times 10^{-4}\\ \\mathrm{L}\\,\\mathrm{mg}^{-1}\\,\\mathrm{min}^{-1}$\n$E_{a}=4.0\\times 10^{4}\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}$\n$R=8.314\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}$\n$T=278.15\\ \\mathrm{K}$\n$T_{\\mathrm{ref}}=293.15\\ \\mathrm{K}$\n\nWe first evaluate the term in the exponent:\n$$\n-\\frac{E_{a}}{R}\\left(\\frac{1}{T}-\\frac{1}{T_{\\mathrm{ref}}}\\right) = -\\frac{4.0\\times 10^{4}\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}}{8.314\\ \\mathrm{J}\\,\\mathrm{mol}^{-1}\\,\\mathrm{K}^{-1}}\\left(\\frac{1}{278.15\\ \\mathrm{K}}-\\frac{1}{293.15\\ \\mathrm{K}}\\right)\n$$\n$$\n\\approx -4811.16\\ \\mathrm{K} \\cdot (0.00359536\\ \\mathrm{K}^{-1} - 0.00341122\\ \\mathrm{K}^{-1})\n$$\n$$\n\\approx -4811.16\\ \\mathrm{K} \\cdot (0.00018414\\ \\mathrm{K}^{-1}) \\approx -0.88591\n$$\nNow, we can calculate $k(T)$:\n$$\nk(278.15\\ \\mathrm{K}) = (1.7\\times 10^{-4}\\ \\mathrm{L}\\,\\mathrm{mg}^{-1}\\,\\mathrm{min}^{-1}) \\exp(-0.88591)\n$$\n$$\nk(278.15\\ \\mathrm{K}) \\approx (1.7\\times 10^{-4})(0.41233) \\approx 7.0096 \\times 10^{-5}\\ \\mathrm{L}\\,\\mathrm{mg}^{-1}\\,\\mathrm{min}^{-1}\n$$\nFinally, we calculate the Ct value required for a $L=3$ log reduction:\n$$\nCt = \\frac{3 \\ln(10)}{k(278.15\\ \\mathrm{K})}\n$$\nUsing the value $\\ln(10) \\approx 2.302585$:\n$$\nCt = \\frac{3 \\times 2.302585}{7.0096 \\times 10^{-5}\\ \\mathrm{L}\\,\\mathrm{mg}^{-1}\\,\\mathrm{min}^{-1}}\n$$\n$$\nCt \\approx \\frac{6.907755}{7.0096 \\times 10^{-5}}\\ \\mathrm{mg}\\cdot\\mathrm{min}\\,\\mathrm{L}^{-1}\n$$\n$$\nCt \\approx 98547\\ \\mathrm{mg}\\cdot\\mathrm{min}\\,\\mathrm{L}^{-1}\n$$\nThe problem requires the answer to be rounded to three significant figures.\n$$\nCt \\approx 9.85 \\times 10^{4}\\ \\mathrm{mg}\\cdot\\mathrm{min}\\,\\mathrm{L}^{-1}\n$$", "answer": "$$\n\\boxed{9.85 \\times 10^{4}}\n$$", "id": "4633472"}, {"introduction": "A positive lab result is not an endpoint but a piece of data that requires careful interpretation within a broader clinical context. This exercise challenges you to move beyond the simple metrics of sensitivity and specificity and apply Bayesian reasoning to a common diagnostic dilemma involving a positive *Giardia* antigen test. You will learn to weigh pre-test probability, shaped by patient history and epidemiology, to determine the true meaning of a test result and make an informed clinical decision. [@problem_id:4633434]", "problem": "A clinical laboratory uses a stool antigen Enzyme Immunoassay (EIA) for Giardia lamblia with analytic performance validated against direct fluorescent antibody testing: sensitivity $95\\%$ and specificity $98\\%$. In a non-outbreak urban setting, four asymptomatic individuals each have a single positive Giardia antigen result. You are asked to interpret each result by applying core definitions from diagnostic testing (sensitivity, specificity, pretest probability), the concept of posterior probability via Bayes’ theorem, and well-established observations about Giardia lamblia epidemiology, including the typical prepatent period of approximately $7$–$14$ days after exposure and intermittent cyst shedding.\n\nWhich scenario most strongly supports interpreting the positive antigen result as evidence of a true, current infection that justifies immediate treatment or public health action without waiting for confirmatory testing?\n\nA. A university student with no travel, no childcare exposure, no known contacts with giardiasis, and no untreated water exposures in the past $2$ months, participating in a screening study in a region where asymptomatic giardiasis prevalence is estimated at $1\\%$.\n\nB. A childcare worker whose household member was laboratory-confirmed with giardiasis $10$ days ago; the worker helps with diapering at both home and work, remains asymptomatic, and submits a stool sample $10$ days after last unprotected exposure.\n\nC. A backpacker who drank from an untreated mountain stream during a $1$-day hike and submitted a stool sample $2$ days after the hike; there is no known giardiasis in close contacts.\n\nD. An adult treated with a standard regimen for giardiasis $10$ days ago after a symptomatic episode, now asymptomatic, who submits a follow-up stool sample that tests positive by the same antigen EIA.\n\nSelect the single best option.", "solution": "The problem asks to identify which of four scenarios provides the strongest justification for interpreting a single positive *Giardia lamblia* antigen test as a true, current infection warranting immediate action, without confirmatory testing. The core of this problem lies in evaluating the posterior probability of infection given a positive test result. This probability is formally known as the Positive Predictive Value (PPV) and is calculated using Bayes' theorem.\n\nThe formula for PPV is:\n$$PPV = P(D+|T+) = \\frac{P(T+|D+) \\times P(D+)}{P(T+|D+) \\times P(D+) + P(T+|D-) \\times P(D-)}$$\nwhere:\n-   $P(D+|T+)$ is the posterior probability of disease (true infection), given a positive test.\n-   $P(T+|D+)$ is the sensitivity of the test, given as $95\\%$ or $0.95$.\n-   $P(D+)$ is the pretest probability (or prevalence) of the disease in the individual being tested.\n-   $P(T+|D-)$ is the false positive rate, which is $1 - \\text{specificity}$. Given the specificity of $98\\%$ or $0.98$, the false positive rate is $1 - 0.98 = 0.02$.\n-   $P(D-)$ is the probability of not having the disease, which is $1 - P(D+)$.\n\nSubstituting the given test characteristics into the formula gives:\n$$PPV = \\frac{0.95 \\times P(D+)}{(0.95 \\times P(D+)) + (0.02 \\times (1 - P(D+)))}$$\nAs the sensitivity ($0.95$) and specificity ($0.98$) of the EIA are constant across all scenarios, the PPV is a monotonically increasing function of the pretest probability, $P(D+)$. Therefore, the scenario with the highest pretest probability of a *current, detectable infection* will yield the highest PPV and provide the strongest evidence for interpreting the positive result as a true positive. We will now analyze each scenario to estimate its relative pretest probability.\n\nA. A university student with no travel, no childcare exposure, no known contacts with giardiasis, and no untreated water exposures in the past $2$ months, participating in a screening study in a region where asymptomatic giardiasis prevalence is estimated at $1\\%$.\n\nIn this scenario, the individual has no specific risk factors for *Giardia* infection. The most appropriate estimate for the pretest probability, $P(D+)$, is the background prevalence in the screening population, which is explicitly given as $1\\%$ or $0.01$. This is a low pretest probability.\nThe corresponding PPV would be:\n$$PPV_A = \\frac{0.95 \\times 0.01}{(0.95 \\times 0.01) + (0.02 \\times (1 - 0.01))} = \\frac{0.0095}{0.0095 + 0.0198} = \\frac{0.0095}{0.0293} \\approx 0.324$$\nA PPV of approximately $32.4\\%$ means there is only a $1$ in $3$ chance that the positive result is a true positive. Conversely, there is a $67.6\\%$ chance it is a false positive. This does not strongly support immediate action without confirmatory testing.\n**Verdict:** Incorrect.\n\nB. A childcare worker whose household member was laboratory-confirmed with giardiasis $10$ days ago; the worker helps with diapering at both home and work, remains asymptomatic, and submits a stool sample $10$ days after last unprotected exposure.\n\nThis scenario describes an individual with multiple, significant risk factors. Household contact with a confirmed case is one of the strongest predictors of infection. The individual is a childcare worker and helps with diapering, both of which are high-risk activities for fecal-oral transmission. Crucially, the timing of the test is highly significant. The sample is submitted $10$ days after exposure, which falls directly within the typical prepatent period of *Giardia lamblia* ($7$–$14$ days). This is the window during which an infected individual would be expected to begin shedding antigens. Therefore, the pretest probability of having a *current, detectable infection* is very high. While a precise value is not given, it is orders of magnitude higher than the $1\\%$ baseline. For instance, assuming a conservative pretest probability of $30\\%$ ($0.30$) due to the strong exposure:\n$$PPV_B = \\frac{0.95 \\times 0.30}{(0.95 \\times 0.30) + (0.02 \\times (1 - 0.30))} = \\frac{0.285}{0.285 + 0.014} = \\frac{0.285}{0.299} \\approx 0.953$$\nWith a PPV of over $95\\%$, the positive result is very likely a true positive. Given the high-risk setting (childcare), immediate treatment and public health action (e.g., temporary removal from work) are strongly justified to prevent an outbreak.\n**Verdict:** Correct.\n\nC. A backpacker who drank from an untreated mountain stream during a $1$-day hike and submitted a stool sample $2$ days after the hike; there is no known giardiasis in close contacts.\n\nThis individual has a known risk factor (drinking untreated water), so the pretest probability is higher than the general population. However, the timing of the test is biologically inconsistent with the known lifecycle of *Giardia lamblia*. The problem states the prepatent period is approximately $7$–$14$ days. This is the time required for ingested cysts to excyst, colonize the small intestine, and multiply to a level where antigens are shed in detectable quantities in the stool. A sample collected only $2$ days after exposure is almost certainly too early to detect a new infection. A positive result at this time is most likely a false positive, or possibly indicative of a pre-existing infection unrelated to the hike. Because the test was taken too early to detect an infection from the specified exposure, the pretest probability of a *detectable* infection resulting from that exposure is effectively zero. The positive result cannot be confidently attributed to that exposure event, making it a weak basis for immediate action.\n**Verdict:** Incorrect.\n\nD. An adult treated with a standard regimen for giardiasis $10$ days ago after a symptomatic episode, now asymptomatic, who submits a follow-up stool sample that tests positive by the same antigen EIA.\n\nThis scenario describes a \"test-of-cure.\" A major limitation of antigen-based tests like EIA for *Giardia* is that parasite antigens can persist in the stool and remain detectable for several weeks (e.g., $3$–$4$ weeks or longer) even after successful parasitological cure. Therefore, a positive antigen test $10$ days after completing treatment is an ambiguous finding. It could indicate treatment failure (a true current infection), but it is also very likely to represent the detection of residual, non-viable antigen from the successfully treated infection. Because of this ambiguity, this result does not strongly support the conclusion of a *current, active* infection that requires immediate re-treatment. Standard clinical practice often discourages using antigen tests for test-of-cure and instead relies on the resolution of symptoms or, if necessary, follow-up microscopy after a longer interval.\n**Verdict:** Incorrect.\n\nIn summary, scenario B presents the ideal confluence of a very high-risk exposure and biologically appropriate timing for testing, leading to the highest pretest probability and, consequently, the highest and most actionable positive predictive value.", "answer": "$$\\boxed{B}$$", "id": "4633434"}, {"introduction": "Why does giardiasis resolve in some individuals but become chronic in others? This question brings us to the heart of host-parasite interactions, particularly the role of the host immune system. This advanced practice introduces a quantitative approach using survival analysis to model the probability of chronic infection in an immunocompromised host. You will translate biological concepts—such as immune-mediated and non-immune clearance pathways—into a mathematical framework to predict clinical outcomes. [@problem_id:4645442]", "problem": "A protozoal infection by Giardia lamblia (giardiasis) in the human small intestine resolves when trophozoites are eliminated. Consider two mechanistically distinct and independent clearance processes acting on trophozoites within a single host: (i) baseline non-immune elimination due to intestinal flow and epithelial turnover, operating as a memoryless process with constant hazard (instantaneous rate) $\\lambda$, and (ii) immune-mediated elimination driven predominantly by secretory Immunoglobulin A (sIgA), which in an Immunoglobulin A-deficient host is impaired and can be modeled as a memoryless process with a reduced constant hazard $\\lambda'$. Assume no reinfection, no exogenous treatment, and that the total time-to-clearance is governed by the first occurrence among these independent clearance pathways (competing risks). Define “chronic giardiasis” as infection that persists longer than a fixed clinical threshold time $\\tau_{c}$.\n\nUsing only fundamental definitions from survival analysis (hazard function, survival function, and independence of competing risks), derive from first principles a closed-form analytic expression for the probability that infection persists beyond time $\\tau_{c}$ in this Immunoglobulin A-deficient host. Express your final answer as a single simplified expression in terms of $\\lambda$, $\\lambda'$, and $\\tau_{c}$. The final result must be unitless and should be expressed as a decimal or a fraction (do not use a percentage). No rounding is required.", "solution": "The user-provided problem is validated as follows.\n\n### Step 1: Extract Givens\n- **Infection**: Giardiasis by *Giardia lamblia* in the human small intestine.\n- **Resolution Condition**: Trophozoites are eliminated.\n- **Process 1**: Baseline non-immune elimination, which is a memoryless process with a constant hazard (instantaneous rate) of $\\lambda$.\n- **Process 2**: Immune-mediated elimination in an Immunoglobulin A-deficient host, which is a memoryless process with a reduced constant hazard of $\\lambda'$.\n- **Independence**: The two clearance processes are mechanistically distinct and independent.\n- **Competing Risks**: The total time-to-clearance is governed by the first occurrence among these independent clearance pathways.\n- **Definition**: \"Chronic giardiasis\" is defined as an infection that persists longer than a fixed clinical threshold time $\\tau_c$.\n- **Assumptions**: No reinfection, no exogenous treatment.\n- **Objective**: Derive a closed-form analytic expression for the probability that infection persists beyond time $\\tau_c$ in this Immunoglobulin A-deficient host, expressed in terms of $\\lambda$, $\\lambda'$, and $\\tau_c$.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, well-posed, and objective. It utilizes standard concepts from survival analysis and epidemiology, namely constant hazard rates, memoryless processes (which correspond to exponential distributions), and independent competing risks. These are common and valid modeling approaches for infectious disease dynamics. The parameters $\\lambda$, $\\lambda'$, and $\\tau_c$ are clearly defined, and the assumptions (independence, no reinfection) make the problem self-contained and solvable. There are no violations of scientific principles, contradictions, or ambiguities.\n\n### Step 3: Verdict and Action\nThe problem is valid and can be solved from first principles.\n\n### Solution Derivation\nThe problem asks for the probability that a *Giardia lamblia* infection persists beyond a time $\\tau_c$. In the language of survival analysis, this is the value of the survival function $S(t)$ at $t=\\tau_c$. The survival function $S(t)$ gives the probability that the event of interest (in this case, clearance of the infection) has not occurred by time $t$.\n\nLet $T$ be the random variable representing the time-to-clearance of the infection. The problem asks for the probability $P(T > \\tau_c)$. By definition, this is $S(\\tau_c)$.\n\nThe clearance of the infection is driven by two independent, competing processes:\n1.  Baseline non-immune elimination, with a constant hazard rate $\\lambda$.\n2.  Impaired immune-mediated elimination, with a constant hazard rate $\\lambda'$.\n\nLet $h_1(t)$ be the hazard function for the first process and $h_2(t)$ be the hazard function for the second process. The problem states these are constant:\n$h_1(t) = \\lambda$\n$h_2(t) = \\lambda'$\n\nThe survival function $S(t)$ is related to the hazard function $h(t)$ by the fundamental equation:\n$$S(t) = \\exp\\left( -\\int_{0}^{t} h(u) \\,du \\right)$$\n\nFor the two competing processes, we can analyze this in two equivalent ways.\n\n**Method 1: Combining Survival Functions**\nLet $S_1(t)$ be the survival function for the first process alone, representing the probability that clearance has *not* occurred via the baseline mechanism by time $t$. Using the formula above:\n$$S_1(t) = \\exp\\left( -\\int_{0}^{t} h_1(u) \\,du \\right) = \\exp\\left( -\\int_{0}^{t} \\lambda \\,du \\right) = \\exp(-\\lambda t)$$\nThis corresponds to the survival function of an exponential distribution with rate parameter $\\lambda$.\n\nSimilarly, let $S_2(t)$ be the survival function for the second process alone:\n$$S_2(t) = \\exp\\left( -\\int_{0}^{t} h_2(u) \\,du \\right) = \\exp\\left( -\\int_{0}^{t} \\lambda' \\,du \\right) = \\exp(-\\lambda' t)$$\n\nThe overall survival from the infection, $S(t)$, is the probability that clearance has not occurred by *either* mechanism by time $t$. Since the two processes are independent, the probability of surviving both simultaneously is the product of their individual survival probabilities:\n$$S(t) = S_1(t) \\times S_2(t)$$\n$$S(t) = \\exp(-\\lambda t) \\times \\exp(-\\lambda' t) = \\exp(-\\lambda t - \\lambda' t)$$\n$$S(t) = \\exp(-(\\lambda + \\lambda') t)$$\n\n**Method 2: Combining Hazard Functions**\nA core principle of independent competing risks is that the overall hazard of the event (clearance) is the sum of the individual hazards of the competing processes. Let $h(t)$ be the overall hazard function for clearance.\n$$h(t) = h_1(t) + h_2(t) = \\lambda + \\lambda'$$\nThe overall hazard rate is constant because the individual rates are constant.\n\nNow, we can find the overall survival function $S(t)$ using this combined hazard rate:\n$$S(t) = \\exp\\left( -\\int_{0}^{t} h(u) \\,du \\right) = \\exp\\left( -\\int_{0}^{t} (\\lambda + \\lambda') \\,du \\right)$$\n$$S(t) = \\exp\\left( -(\\lambda + \\lambda') \\int_{0}^{t} 1 \\,du \\right) = \\exp(-(\\lambda + \\lambda') t)$$\nBoth methods yield the same overall survival function, confirming the consistency of the approach.\n\nThe problem asks for the probability that the infection persists beyond the clinical threshold time $\\tau_c$. This is simply $S(t)$ evaluated at $t = \\tau_c$.\n$$P(\\text{infection persists beyond } \\tau_c) = S(\\tau_c) = \\exp(-(\\lambda + \\lambda') \\tau_c)$$\n\nThis expression is a dimensionless probability, as the units of $\\lambda$ and $\\lambda'$ are inverse time (e.g., $day^{-1}$) and the unit of $\\tau_c$ is time (e.g., $days$), making the exponent $(\\lambda + \\lambda')\\tau_c$ a dimensionless quantity.\nThe final expression is the derived probability.", "answer": "$$\\boxed{\\exp(-(\\lambda + \\lambda')\\tau_{c})}$$", "id": "4645442"}]}